Home > Products > CD55 & CA9 > Recombinant Human Anti-CD55 x Human Anti-CA9 Bispecific Antibody (F(ab')2-scFv2)

Recombinant Human Anti-CD55 x Human Anti-CA9 Bispecific Antibody (F(ab')2-scFv2)  (CAT#: BABFV-H297)

Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (F(ab')2-scFv2) is designed to be expressed as two chains combined via a hinge region. The scFv of the anti-CD55 specificity is fused to the C terminus of the anti-CA9 Fab fragment, or vice versa. This format comprises four binding sites (two same scFv regions and two same Fab fragments), two for each antigen. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
Datasheet INQUIRY

Specifications

Targets
CD55 & CA9
Type
F(ab')2-scFv2
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Renal cell cancer (RCC); Solid tumors
Host Animal 1
Human
Host Animal 2
Human

Targets

Target 1
CD55
Gene ID
UniProt ID
Alternative Names
CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen
Target 2
CA9
Gene ID
UniProt ID
Alternative Names
CA9; carbonic anhydrase 9; RCC-associated antigen G250; G250; CA-IX; carbonic anhydrase IX; MN; CAH9
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD55 & CA9"
See other bsAb targets related to "CD55"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD55 x Human Anti-CA9 Bispecific Antibody (F(ab')2-scFv2) (BABFV-H297). Click the button below to contact us or submit your feedback about this product.